Citation: Pb. Mckinzie et al., Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment, MUT RES-R M, 489(1), 2001, pp. 47-78
Authors:
Chen, T
Mittelstaedt, RA
Aidoo, A
Hamilton, LP
Beland, FA
Casciano, DA
Heflich, RH
Citation: T. Chen et al., Comparison of hprt and lacl mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminoflourene-treated Big Blue((R)) rats, ENV MOL MUT, 37(3), 2001, pp. 195-202
Authors:
Chen, T
Mittelstaedt, RA
Shelton, SD
Dass, SB
Manjanatha, MG
Casciano, DA
Heflich, RH
Citation: T. Chen et al., Gene- and tissue-specificity of mutation in Big Blue (R) rats treated withthe hepatocarcinogen N-hydroxy-2-acetylaminofluorene, ENV MOL MUT, 37(3), 2001, pp. 203-214
Authors:
da Costa, GG
McDaniel-Hamilton, LP
Heflich, RH
Marques, MM
Beland, FA
Citation: Gg. Da Costa et al., DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives, CARCINOGENE, 22(8), 2001, pp. 1307-1315
Authors:
Meng, QX
Singh, N
Heflich, RH
Bauer, MJ
Walker, VE
Citation: Qx. Meng et al., Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2 : 3,4-diepoxybutane, MUT RES-GTE, 464(2), 2000, pp. 169-184
Citation: Vn. Dobrovolsky et al., 7,12-Dimethylbenz[a]anthracene-induced mutation in the Tk gene of Tk(+/-) mice: Automated scoring of lymphocyte clones using a fluorescent viability indicator, ENV MOL MUT, 36(4), 2000, pp. 283-291
Authors:
Casciano, DA
Aidoo, A
Chen, T
Mittelstaedt, RA
Manjanatha, MG
Heflich, RH
Citation: Da. Casciano et al., Hprt mutant frequency and molecular analysis of Hprt mutations in rats treated with mutagenic carcinogens, MUT RES-F M, 431(2), 1999, pp. 389-395
Authors:
Mittelstaedt, RA
Smith, BA
Chen, T
Beland, FA
Heflich, RH
Citation: Ra. Mittelstaedt et al., Sequence specificity of Hprt lymphocyte mutation in rats fed the hepatocarcinogen 2-acetylaminofluorene, MUT RES-F M, 431(1), 1999, pp. 167-173
Authors:
Meng, QX
Henderson, RF
Chen, T
Heflich, RH
Walker, DM
Bauer, MJ
Reilly, AA
Walker, VE
Citation: Qx. Meng et al., Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes followinginhalation exposures of female mice and rats, MUT RES-F M, 429(1), 1999, pp. 107-125
Citation: Vn. Dobrovolsky et al., Tk(+/-) mouse model for detecting in vivo mutation in an endogenous, autosomal gene, MUT RES-F M, 423(1-2), 1999, pp. 125-136
Citation: Jb. Chen et al., Development of a mouse cell line containing the phi X174 am3 allele as a target for detecting mutation, MUT RES-GTE, 444(2), 1999, pp. 347-353
Citation: Vn. Dobrovolsky et al., Molecular analysis of in vivo mutations induced by N-ethyl-N-nitrosourea in the autosomal Tk and the X-linked Hprt genes of mouse lymphocytes, ENV MOL MUT, 34(1), 1999, pp. 30-38
Authors:
Von Tungeln, LS
Xia, QS
Herreno-Saenz, D
Bucci, TJ
Heflich, RH
Fu, PP
Citation: Ls. Von Tungeln et al., Tumorigenicity of nitropolycyclic aromatic hydrocarbons in the neonatal B6C3F(1) mouse bioassay and characterization of ras mutations in liver tumorsfrom treated mice, CANCER LETT, 146(1), 1999, pp. 1-7
Authors:
Beland, FA
Fullerton, NF
Smith, BA
Mittelstaedt, RA
Heflich, RH
Citation: Fa. Beland et al., Hprt lymphocyte mutant frequency in relation to DNA adduct formation in rats fed the hepatocarcinogen 2-acetylaminofluorene, CANCER LETT, 143(2), 1999, pp. 249-255
Authors:
Dass, SB
Bucci, TJ
Heflich, RH
Casciano, DA
Citation: Sb. Dass et al., Evaluation of the transgenic p53(+/-) mouse for detecting genotoxic liver carcinogens in a short-term bioassay, CANCER LETT, 143(1), 1999, pp. 81-85
Authors:
Von Tungeln, LS
Xia, QS
Bucci, T
Heflich, RH
Fu, PP
Citation: Ls. Von Tungeln et al., Tumorigenicity and liver tumor ras-protooncogene mutations in CD-1 mice treated neonatally with 1-and 3-nitrobenzo[a]pyrene and their trans-7,8-dihydrodiol and aminobenzo[a]pyrene metabolites, CANCER LETT, 137(2), 1999, pp. 137-143
Authors:
Chen, T
Aidoo, A
Mittelstaedt, RA
Casciano, DA
Heflich, RH
Citation: T. Chen et al., Hprt mutant frequency and molecular analysis of Hprt mutations in Fischer 344 rats treated with thiotepa, CARCINOGENE, 20(2), 1999, pp. 269-277